ClinicalTrialsFinder

Recurrent B-Cell Prolymphocytic Leukemia Clinical Trials in Columbus, Ohio

1 recruitingColumbus, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 1

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Recurrent Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaRecurrent Non-Hodgkin Lymphoma+15 more
Sumithira Vasu54 enrolled2 locationsNCT05418088